Caroline Apergi-Palm
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.
Journal: Blood cancer journal
Published: July 03, 2023
Protein Delivery by PTDs/CPPs.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 12, 2021
Small-molecule inhibitors for targeting polo-like kinase 1.
Journal: Future medicinal chemistry
Published: July 09, 2020
Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western Blot.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 15, 2019
STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes.
Journal: Scientific reports
Published: May 25, 2018
Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.
Journal: Nucleic acid therapeutics
Published: September 22, 2017
RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 17, 2017
Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
Journal: PloS one
Published: March 13, 2017
Last Updated: 09/26/2026